glp 1 and alzheimer's disease Glucagon like peptide-1 (GLP-1) likes Dementia and Alzheimer's Disease Risk

There were 180 patients who started taking repaglinide but were not in the repaglinide and clopidogrel group, and 15 of these were matched to the patients in the repaglinide and clopidogrel group and were analyzed as the repaglinide group (Table 1)

10.1007/s10620-010-1307-1 Mutlu-Trkolu , Erbil Y, ztezcan S, Olga V, Token G, Uysal M: The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats

PubMed , Biochimica Et Biophysica Acta

Y.ChoD.LeeJ

Nat Rev Nephrol 13:605 Skov J (2014) Effects of GLP-1 in the Kidney

A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics